Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Cosmetic – antiperspirant – dentifrice
Reexamination Certificate
2006-04-04
2006-04-04
Dodson, Shelly A. (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Cosmetic, antiperspirant, dentifrice
C424S059000, C424S060000, C424S400000, C424S703000, C514S859000, C514S861000, C514S863000, C514S864000
Reexamination Certificate
active
07022332
ABSTRACT:
The present invention provides improved sulfacetamide and sulfur formulations including sunscreens for the treatment of rosacea.
REFERENCES:
patent: 4895727 (1990-01-01), Allen
patent: 5017366 (1991-05-01), Stiefel et al.
patent: 6482839 (2002-11-01), Thornfeldt
E. Bonnar, et al., The Demodex mite population in rosacea, Journal of the American Academy of Dermatology, Mar. 1993, pp. 443-448.
Johnathan K. Wilkin, Flushing Disorders, Principles and Practice of Dermatology, Sams and Lynch Editors, 1990, pp. 495-500.
A.P. Kelly, Rosacea, Priciples and Practice of Dermatology, Sams and Lynch Editors, 1990, pp. 789-791.
Food and Drug Administration, Sunscreen Drug Products for Over-The-Counter Human Use, Final Monograph, Federal Register, May 21, 1999, vol. 64, No. 98, pp. 1-54.
Dodson Shelly A.
Fischer Ury
Keller Michael J.
Lott & Friedland, P.A.
Stiefel Laboratories, Inc.
LandOfFree
Sulfacetamide formulations for treatment of rosacea does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfacetamide formulations for treatment of rosacea, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfacetamide formulations for treatment of rosacea will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3525743